LAB
Standard Biotools Inc
0.742$
-1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -45.0% | -49.9% | -137.2% | -173.6% | -62.0% | -30.1% | -149.8% | -95.0% | -113.6% | -5.0% | -220.4% | -51.3% | -94.9% | |
| 15.7% | 13.9% | 11.4% | 17.1% | 8.6% | 8.5% | 20.6% | 18.4% | 28.6% | 5.4% | 6.7% | 6.3% | 11.3% | |
| 13.3% | 12.3% | 7.8% | 29.9% | 13.2% | 16.0% | 44.6% | 24.7% | 38.5% | 24.1% | 41.7% | 20.1% | 30.9% | |
| 6.7% | -5.7% | -23.0% | -17.9% | -23.8% | 18.6% | -77.1% | -0.1% | -6.0% | -130.0% | -259.8% | 230.4% | -48.1% | |
| 3.6% | 0.3% | 1.7% | 8.6% | 5.0% | 7.2% | 25.0% | 8.7% | 4.5% | 2.0% | 2.7% | 1.7% | 2.7% | |
| -196.8% | -46.5% | 698.5% | 223.4% | -68.7% | 55.1% | 72.3% | 126.4% | -34.2% | -44.9% | 903.7% | 71.7% | 222.4% | |
| 0.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.6% | -0.6% | -24.3% | -130.9% | -0.2% | -0.1% | -0.2% | -0.9% | -0.6% | 0.2% | – | – | – | |
| – | – | – | – | 0.0% | -117.7% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | |
| -4.6% | -3.6% | -43.3% | -126.1% | 0.0% | -116.7% | -0.2% | 0.5% | -0.6% | 2.6% | -0.2% | -0.7% | 0.4% | |
| -247.0% | -99.2% | 517.9% | -76.7% | -131.6% | -92.3% | -75.9% | 35.5% | -149.3% | -47.7% | 683.7% | 21.2% | 128.0% | |
| -48.6% | -50.2% | -138.9% | -182.2% | -67.0% | -37.3% | -174.7% | -103.6% | -118.1% | -7.0% | -223.1% | -53.0% | -97.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.